Showing results (1941-1950 of 2,976) with videos related to
Sort By:
Pageof 298
European Journal of Epidemiology|May 15, 2023
Diabetes mellitus, prediabetes and the risk of Parkinson's disease: a systematic review and meta-analysis of 15 cohort studies with 29.9 million participants and 86,345 casesDagfinn Aune, Sabrina Schlesinger, Yahya Mahamat-Saleh, et al.American Journal of Public Health|July 1, 1989
Containing mental health treatment costs through program design: a Massachusetts studyB Dickey, P R Binner, S Leff, et al.European Journal of Internal Medicine|November 2, 2015
The association between glycated hemoglobin levels and mortality in non-diabetic elderly subjectsAlon Grossman, Yichayahou Beloosesky, Agatha Schlesinger, et al.Pharmaceutical Research|March 16, 2016
A Tunable, Biodegradable, Thin-Film Polymer Device as a Long-Acting Implant Delivering Tenofovir Alafenamide Fumarate for HIV Pre-exposure ProphylaxisErica Schlesinger, Daniel Johengen, Ellen Luecke, et al.International Journal of Radiation Oncology, Biology, Physics|November 5, 2015
Leukoencephalopathy After Stereotactic Radiosurgery for Brain MetastasesDaniel M Trifiletti, Cheng-Chia Lee, David Schlesinger, et al.Archives of Disease in Childhood|June 12, 1998
Hereditary CD4+ T lymphocytopeniaS Freier, E Kerem, Z Dranitzki, et al.Vaccine|August 1, 2016
Impact of PCV7/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPDS Ben-Shimol, D Greenberg, N Givon-Lavi, et al.Seminars in Arthritis and Rheumatism|June 26, 2025
Incidence of gout diagnosis among participants with hyperuricemia, insights from a nationwide cohort studyShay Brikman, Oriel Perets, Liel Serfaty, et al.Acta Neurochirurgica|March 14, 2025
Leukoencephalopathy following stereotactic radiosurgery for breast cancer brain metastases: a single-center analysis of 1,077 lesionsSalem M Tos, Bardia Hajikarimloo, Georgios Mantziaris, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 3, 2015
Targeted delivery of CCR2 antagonist to activated pulmonary endothelium prevents metastasisMarko Roblek, Manuela Calin, Martin Schlesinger, et al.Pageof 298